Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

Published:2016-10 Issue:10 Volume:22 Page:845-850
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Münch Julia,Avanesov Maxim,Bannas Peter,Säring Dennis,Krämer Elisabeth,Mearini Giulia,Carrier Lucie,Suling Anna,Lund Gunnar,Patten Monica

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

2. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications;Paya;J Card Fail,2008

3. Myofibroblast-mediated mechanisms of pathological remodelling of the heart;Weber;Nat Rev Cardiol,2013

4. Myocardial collagen turnover in hypertrophic cardiomyopathy;Lombardi;Circulation,2003

5. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy;Roldan;Am Heart J,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The MMP-9 promoter genetic variant rs3918242, mRNA and protein expression in advanced carotid plaque tissue;Molecular Biology Reports;2024-04-20

2. Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy;Cardiovascular Therapy and Prevention;2024-02-07

3. Biomarkers in Peripartum Cardiomyopathy—What We Know and What Is Still to Be Found;Biomolecules;2024-01-12

4. Role and new insights of microfibrillar‐associated protein 4 in fibrotic diseases;APMIS;2023-11-13

5. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies;Molecular Aspects of Medicine;2023-10